MARKET

CELG-RT

CELG-RT

Bristol-Myers Squibb Company Celegne Contingent Value Rights
NYSE
0.0474
-0.0026
-5.20%
Opening 10:23 04/01 EDT
OPEN
0.0474
PREV CLOSE
0.0500
HIGH
0.0474
LOW
0.0474
VOLUME
205
TURNOVER
--
52 WEEK HIGH
0.1550
52 WEEK LOW
0.0150
MARKET CAP
33.72M
P/E (TTM)
-0.0107
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CELG RT last week (0324-0328)?
Weekly Report · 1d ago
Weekly Report: what happened at CELG RT last week (0317-0321)?
Weekly Report · 03/24 09:13
Weekly Report: what happened at CELG RT last week (0310-0314)?
Weekly Report · 03/17 09:14
Weekly Report: what happened at CELG RT last week (0303-0307)?
Weekly Report · 03/10 09:15
Weekly Report: what happened at CELG RT last week (0224-0228)?
Weekly Report · 03/03 09:15
Weekly Report: what happened at CELG RT last week (0217-0221)?
Weekly Report · 02/24 09:15
Weekly Report: what happened at CELG RT last week (0210-0214)?
Weekly Report · 02/17 09:14
Bristol-Myers Squibb Company Annual Report (Form 10-K) for the fiscal year ended December 31, 2024
Press release · 02/12 21:01
More
About CELG-RT
More
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its platforms comprise chemically synthesized or small molecule drugs, including protein degraders; drugs produced from biological processes, called biologics; ADCs, CAR-T cell therapies, and radiopharmaceutical therapeutics. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are also used. Biologics are typically administered through injections or by intravenous infusion. CAR-T cell therapies are administered by intravenous infusion. Its growth portfolio includes Opdivo, Opdivo Qvantig, Orencia, Yervoy, Reblozyl, Opdualag, and others. Its legacy portfolio includes Eliquis, Revlimid, Pomalyst/Imnovid, Sprycel and Abraxane.
Recently
Symbol
Price
%Change

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: CELG RT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELG RT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CELG-RT stock methods without spending real money on the virtual paper trading platform.